nodes	percent_of_prediction	percent_of_DWPC	metapath
Lumiracoxib—Bromfenac—Balsalazide—ulcerative colitis	0.298	1	CrCrCtD
Lumiracoxib—PTGS1—ulcerative colitis	0.195	0.636	CbGaD
Lumiracoxib—PTGS2—ulcerative colitis	0.111	0.364	CbGaD
Lumiracoxib—PTGS2—Olsalazine—ulcerative colitis	0.0501	0.13	CbGbCtD
Lumiracoxib—PTGS2—Balsalazide—ulcerative colitis	0.0447	0.116	CbGbCtD
Lumiracoxib—PTGS1—Olsalazine—ulcerative colitis	0.0423	0.11	CbGbCtD
Lumiracoxib—PTGS1—Balsalazide—ulcerative colitis	0.0377	0.0981	CbGbCtD
Lumiracoxib—PTGS2—Mesalazine—ulcerative colitis	0.0357	0.0928	CbGbCtD
Lumiracoxib—PTGS1—Mesalazine—ulcerative colitis	0.0302	0.0784	CbGbCtD
Lumiracoxib—PTGS2—Sulfasalazine—ulcerative colitis	0.02	0.0519	CbGbCtD
Lumiracoxib—PTGS2—Triamcinolone—ulcerative colitis	0.02	0.0519	CbGbCtD
Lumiracoxib—PTGS2—Betamethasone—ulcerative colitis	0.0171	0.0445	CbGbCtD
Lumiracoxib—PTGS1—Sulfasalazine—ulcerative colitis	0.0168	0.0438	CbGbCtD
Lumiracoxib—CYP2C19—Nicotine—ulcerative colitis	0.0105	0.0273	CbGbCtD
Lumiracoxib—PTGS2—Dexamethasone—ulcerative colitis	0.00996	0.0259	CbGbCtD
Lumiracoxib—CYP1A2—Nicotine—ulcerative colitis	0.00968	0.0252	CbGbCtD
Lumiracoxib—CYP2C19—Cholecalciferol—ulcerative colitis	0.00941	0.0245	CbGbCtD
Lumiracoxib—CYP2C9—Nicotine—ulcerative colitis	0.00872	0.0227	CbGbCtD
Lumiracoxib—CYP2C9—Cholecalciferol—ulcerative colitis	0.00782	0.0203	CbGbCtD
Lumiracoxib—CYP2C19—Prednisone—ulcerative colitis	0.00652	0.017	CbGbCtD
Lumiracoxib—CYP2C19—Dexamethasone—ulcerative colitis	0.00407	0.0106	CbGbCtD
Lumiracoxib—CYP2C9—Dexamethasone—ulcerative colitis	0.00338	0.0088	CbGbCtD
Lumiracoxib—Diclofenac—CXCR1—ulcerative colitis	0.000998	0.253	CrCbGaD
Lumiracoxib—PTGS2—Fluocinonide—Budesonide—ulcerative colitis	0.000488	0.247	CbGdCrCtD
Lumiracoxib—PTGS1—Overview of nanoparticle effects—CDH3—ulcerative colitis	0.000486	0.0779	CbGpPWpGaD
Lumiracoxib—Tolmetin—CXCL8—ulcerative colitis	0.000457	0.116	CrCbGaD
Lumiracoxib—PTGS2—Overview of nanoparticle effects—CDH3—ulcerative colitis	0.000386	0.0619	CbGpPWpGaD
Lumiracoxib—Tolmetin—MPO—ulcerative colitis	0.000356	0.0902	CrCbGaD
Lumiracoxib—Bromfenac—PTGS1—ulcerative colitis	0.000347	0.088	CrCbGaD
Lumiracoxib—Diclofenac—CXCL8—ulcerative colitis	0.000252	0.0638	CrCbGaD
Lumiracoxib—PTGS2—Fluocinonide—Methylprednisolone—ulcerative colitis	0.000236	0.119	CbGdCrCtD
Lumiracoxib—PTGS2—Calcium signaling in the CD4+ TCR pathway—CHP1—ulcerative colitis	0.000234	0.0375	CbGpPWpGaD
Lumiracoxib—Tolmetin—PTGS1—ulcerative colitis	0.000233	0.0591	CrCbGaD
Lumiracoxib—PTGS2—Fluocinonide—Dexamethasone—ulcerative colitis	0.000232	0.118	CbGdCrCtD
Lumiracoxib—PTGS2—Fluocinonide—Betamethasone—ulcerative colitis	0.000232	0.118	CbGdCrCtD
Lumiracoxib—Meclofenamic acid—PTGS1—ulcerative colitis	0.00023	0.0583	CrCbGaD
Lumiracoxib—PTGS2—Fluocinonide—Triamcinolone—ulcerative colitis	0.000227	0.115	CbGdCrCtD
Lumiracoxib—Bromfenac—PTGS2—ulcerative colitis	0.000198	0.0503	CrCbGaD
Lumiracoxib—UGT1A9—NRF2 pathway—SLC39A11—ulcerative colitis	0.000181	0.029	CbGpPWpGaD
Lumiracoxib—Mefenamic acid—PTGS1—ulcerative colitis	0.000179	0.0453	CrCbGaD
Lumiracoxib—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS1—ulcerative colitis	0.000175	0.028	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IKZF1—ulcerative colitis	0.000159	0.0254	CbGpPWpGaD
Lumiracoxib—PTGS2—Fluticasone Propionate—Methylprednisolone—ulcerative colitis	0.000142	0.0721	CbGdCrCtD
Lumiracoxib—PTGS2—Fluticasone Propionate—Betamethasone—ulcerative colitis	0.00014	0.0709	CbGdCrCtD
Lumiracoxib—PTGS2—Fluticasone Propionate—Dexamethasone—ulcerative colitis	0.00014	0.0709	CbGdCrCtD
Lumiracoxib—PTGS2—C-MYB transcription factor network—PRTN3—ulcerative colitis	0.000138	0.0222	CbGpPWpGaD
Lumiracoxib—PTGS2—Overview of nanoparticle effects—PTGS1—ulcerative colitis	0.000137	0.0219	CbGpPWpGaD
Lumiracoxib—PTGS2—Fluticasone Propionate—Triamcinolone—ulcerative colitis	0.000137	0.0693	CbGdCrCtD
Lumiracoxib—Tolmetin—PTGS2—ulcerative colitis	0.000133	0.0338	CrCbGaD
Lumiracoxib—Meclofenamic acid—PTGS2—ulcerative colitis	0.000131	0.0333	CrCbGaD
Lumiracoxib—Diclofenac—PTGS1—ulcerative colitis	0.000128	0.0326	CrCbGaD
Lumiracoxib—PTGS1—Prostaglandin Synthesis and Regulation—PTGER4—ulcerative colitis	0.000122	0.0195	CbGpPWpGaD
Lumiracoxib—PTGS2—Eicosanoid Synthesis—PTGS1—ulcerative colitis	0.000114	0.0182	CbGpPWpGaD
Lumiracoxib—Mefenamic acid—PTGS2—ulcerative colitis	0.000102	0.0259	CrCbGaD
Lumiracoxib—PTGS1—Overview of nanoparticle effects—CRP—ulcerative colitis	9.86e-05	0.0158	CbGpPWpGaD
Lumiracoxib—UGT1A9—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	9.76e-05	0.0157	CbGpPWpGaD
Lumiracoxib—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL12B—ulcerative colitis	9.7e-05	0.0155	CbGpPWpGaD
Lumiracoxib—PTGS2—Prostaglandin Synthesis and Regulation—PTGER4—ulcerative colitis	9.65e-05	0.0155	CbGpPWpGaD
Lumiracoxib—PTGS2—Prostaglandin Synthesis and Regulation—PTGS1—ulcerative colitis	9.5e-05	0.0152	CbGpPWpGaD
Lumiracoxib—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—ulcerative colitis	9.08e-05	0.0146	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcium signaling in the CD4+ TCR pathway—CALM3—ulcerative colitis	8.79e-05	0.0141	CbGpPWpGaD
Lumiracoxib—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—ulcerative colitis	8.44e-05	0.0135	CbGpPWpGaD
Lumiracoxib—PTGS2—Overview of nanoparticle effects—CRP—ulcerative colitis	7.83e-05	0.0125	CbGpPWpGaD
Lumiracoxib—Diclofenac—PTGS2—ulcerative colitis	7.34e-05	0.0186	CrCbGaD
Lumiracoxib—PTGS1—Overview of nanoparticle effects—PTGS2—ulcerative colitis	6.61e-05	0.0106	CbGpPWpGaD
Lumiracoxib—Diclofenac—ALB—ulcerative colitis	6.54e-05	0.0166	CrCbGaD
Lumiracoxib—PTGS1—Overview of nanoparticle effects—CXCL8—ulcerative colitis	6.41e-05	0.0103	CbGpPWpGaD
Lumiracoxib—PTGS2—Arachidonic acid metabolism—PTGS1—ulcerative colitis	6.31e-05	0.0101	CbGpPWpGaD
Lumiracoxib—Diclofenac—ABCB1—ulcerative colitis	6.25e-05	0.0158	CrCbGaD
Lumiracoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CALM3—ulcerative colitis	5.69e-05	0.00911	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—ulcerative colitis	5.52e-05	0.00885	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—MPO—ulcerative colitis	5.5e-05	0.00881	CbGpPWpGaD
Lumiracoxib—PTGS1—Eicosanoid Synthesis—PTGS2—ulcerative colitis	5.48e-05	0.00879	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—MIF—ulcerative colitis	5.32e-05	0.00853	CbGpPWpGaD
Lumiracoxib—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—ulcerative colitis	5.23e-05	0.00838	CbGpPWpGaD
Lumiracoxib—PTGS2—Overview of nanoparticle effects—CXCL8—ulcerative colitis	5.09e-05	0.00816	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—MST1—ulcerative colitis	4.62e-05	0.0074	CbGpPWpGaD
Lumiracoxib—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	4.59e-05	0.00736	CbGpPWpGaD
Lumiracoxib—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—ulcerative colitis	4.59e-05	0.00735	CbGpPWpGaD
Lumiracoxib—CYP2C19—Arachidonic acid metabolism—PTGS1—ulcerative colitis	4.59e-05	0.00735	CbGpPWpGaD
Lumiracoxib—PTGS2—C-MYB transcription factor network—MPO—ulcerative colitis	4.53e-05	0.00726	CbGpPWpGaD
Lumiracoxib—PTGS1—Overview of nanoparticle effects—TNF—ulcerative colitis	4.46e-05	0.00715	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—MPO—ulcerative colitis	4.37e-05	0.007	CbGpPWpGaD
Lumiracoxib—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	4.18e-05	0.00671	CbGpPWpGaD
Lumiracoxib—CYP2C9—Arachidonic acid metabolism—PTGS1—ulcerative colitis	4.18e-05	0.0067	CbGpPWpGaD
Lumiracoxib—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IFNG—ulcerative colitis	4.17e-05	0.00668	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—PTGS1—ulcerative colitis	4.02e-05	0.00644	CbGpPWpGaD
Lumiracoxib—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	3.99e-05	0.00639	CbGpPWpGaD
Lumiracoxib—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	3.98e-05	0.00638	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—ulcerative colitis	3.9e-05	0.00626	CbGpPWpGaD
Lumiracoxib—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL1B—ulcerative colitis	3.72e-05	0.00596	CbGpPWpGaD
Lumiracoxib—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL2—ulcerative colitis	3.71e-05	0.00594	CbGpPWpGaD
Lumiracoxib—UGT1A9—Biological oxidations—PTGS1—ulcerative colitis	3.63e-05	0.00582	CbGpPWpGaD
Lumiracoxib—PTGS1—Overview of nanoparticle effects—IL6—ulcerative colitis	3.6e-05	0.00577	CbGpPWpGaD
Lumiracoxib—CYP1A2—Arachidonic acid metabolism—PTGS1—ulcerative colitis	3.57e-05	0.00573	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—ulcerative colitis	3.55e-05	0.00569	CbGpPWpGaD
Lumiracoxib—PTGS2—Overview of nanoparticle effects—TNF—ulcerative colitis	3.54e-05	0.00568	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—FCGR2A—ulcerative colitis	3.5e-05	0.0056	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—ulcerative colitis	3.47e-05	0.00556	CbGpPWpGaD
Lumiracoxib—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	3.41e-05	0.00546	CbGpPWpGaD
Lumiracoxib—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	3.4e-05	0.00545	CbGpPWpGaD
Lumiracoxib—CYP2C19—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	3.21e-05	0.00515	CbGpPWpGaD
Lumiracoxib—CYP1A2—Estrogen Receptor Pathway—STAT3—ulcerative colitis	3.14e-05	0.00503	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—ulcerative colitis	3.08e-05	0.00493	CbGpPWpGaD
Lumiracoxib—PTGS1—Arachidonic acid metabolism—PTGS2—ulcerative colitis	3.05e-05	0.00489	CbGpPWpGaD
Lumiracoxib—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	2.93e-05	0.0047	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—CRP—ulcerative colitis	2.89e-05	0.00464	CbGpPWpGaD
Lumiracoxib—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TGFB1—ulcerative colitis	2.89e-05	0.00463	CbGpPWpGaD
Lumiracoxib—PTGS2—Overview of nanoparticle effects—IL6—ulcerative colitis	2.86e-05	0.00458	CbGpPWpGaD
Lumiracoxib—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	2.77e-05	0.00445	CbGpPWpGaD
Lumiracoxib—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—ulcerative colitis	2.7e-05	0.00433	CbGpPWpGaD
Lumiracoxib—PTGS2—Aryl Hydrocarbon Receptor—RELA—ulcerative colitis	2.66e-05	0.00427	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—ICAM1—ulcerative colitis	2.66e-05	0.00426	CbGpPWpGaD
Lumiracoxib—UGT1A9—PPARA activates gene expression—PPARG—ulcerative colitis	2.53e-05	0.00405	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—ulcerative colitis	2.52e-05	0.00405	CbGpPWpGaD
Lumiracoxib—CYP1A2—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	2.5e-05	0.00401	CbGpPWpGaD
Lumiracoxib—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—ulcerative colitis	2.48e-05	0.00397	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—HNF4A—ulcerative colitis	2.42e-05	0.00389	CbGpPWpGaD
Lumiracoxib—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	2.37e-05	0.0038	CbGpPWpGaD
Lumiracoxib—CYP2C19—Melatonin metabolism and effects—NFKB1—ulcerative colitis	2.36e-05	0.00378	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—ulcerative colitis	2.35e-05	0.00376	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—CRP—ulcerative colitis	2.3e-05	0.00368	CbGpPWpGaD
Lumiracoxib—PTGS2—Aryl Hydrocarbon Receptor—NFKB1—ulcerative colitis	2.25e-05	0.0036	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—ulcerative colitis	2.24e-05	0.0036	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—ALB—ulcerative colitis	2.22e-05	0.00355	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—ICAM1—ulcerative colitis	2.11e-05	0.00338	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—IFNG—ulcerative colitis	2.02e-05	0.00324	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—RELA—ulcerative colitis	2e-05	0.0032	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—PTGS2—ulcerative colitis	1.94e-05	0.00311	CbGpPWpGaD
Lumiracoxib—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—ulcerative colitis	1.92e-05	0.00307	CbGpPWpGaD
Lumiracoxib—CYP1A2—Melatonin metabolism and effects—NFKB1—ulcerative colitis	1.84e-05	0.00295	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—IL1B—ulcerative colitis	1.8e-05	0.00289	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—ALB—ulcerative colitis	1.76e-05	0.00282	CbGpPWpGaD
Lumiracoxib—CYP2C19—Arachidonic acid metabolism—PTGS2—ulcerative colitis	1.76e-05	0.00282	CbGpPWpGaD
Lumiracoxib—PTGS2—Aryl Hydrocarbon Receptor—TNF—ulcerative colitis	1.75e-05	0.0028	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—TLR4—ulcerative colitis	1.74e-05	0.00279	CbGpPWpGaD
Lumiracoxib—CYP2C19—Biological oxidations—PTGS1—ulcerative colitis	1.71e-05	0.00274	CbGpPWpGaD
Lumiracoxib—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—ulcerative colitis	1.71e-05	0.00273	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—NFKB1—ulcerative colitis	1.68e-05	0.0027	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—ICAM1—ulcerative colitis	1.67e-05	0.00268	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—ulcerative colitis	1.63e-05	0.00262	CbGpPWpGaD
Lumiracoxib—PTGS2—C-MYB transcription factor network—CD4—ulcerative colitis	1.61e-05	0.00258	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—IFNG—ulcerative colitis	1.61e-05	0.00257	CbGpPWpGaD
Lumiracoxib—CYP2C9—Arachidonic acid metabolism—PTGS2—ulcerative colitis	1.6e-05	0.00257	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—RELA—ulcerative colitis	1.58e-05	0.00254	CbGpPWpGaD
Lumiracoxib—CYP2C9—Biological oxidations—PTGS1—ulcerative colitis	1.56e-05	0.00249	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—ulcerative colitis	1.53e-05	0.00245	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—ulcerative colitis	1.51e-05	0.00243	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—RELA—ulcerative colitis	1.51e-05	0.00241	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—CHP1—ulcerative colitis	1.49e-05	0.00239	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—ulcerative colitis	1.46e-05	0.00235	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—IL1B—ulcerative colitis	1.43e-05	0.0023	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	1.39e-05	0.00224	CbGpPWpGaD
Lumiracoxib—CYP1A2—Arachidonic acid metabolism—PTGS2—ulcerative colitis	1.37e-05	0.00219	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—ulcerative colitis	1.36e-05	0.00218	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—ulcerative colitis	1.36e-05	0.00217	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—NFKB1—ulcerative colitis	1.34e-05	0.00214	CbGpPWpGaD
Lumiracoxib—CYP1A2—Biological oxidations—PTGS1—ulcerative colitis	1.33e-05	0.00213	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—TNF—ulcerative colitis	1.31e-05	0.0021	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—DLD—ulcerative colitis	1.28e-05	0.00206	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—ulcerative colitis	1.27e-05	0.00204	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—IFNG—ulcerative colitis	1.27e-05	0.00204	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—CHP1—ulcerative colitis	1.21e-05	0.00194	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—CXCL8—ulcerative colitis	1.18e-05	0.00189	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CHP1—ulcerative colitis	1.15e-05	0.00184	CbGpPWpGaD
Lumiracoxib—UGT1A9—NRF2 pathway—TGFB1—ulcerative colitis	1.15e-05	0.00184	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—IL1B—ulcerative colitis	1.13e-05	0.00182	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—IL2—ulcerative colitis	1.13e-05	0.00181	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—MMP9—ulcerative colitis	1.07e-05	0.00171	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—ulcerative colitis	1.06e-05	0.0017	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—IL6—ulcerative colitis	1.06e-05	0.00169	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—DLD—ulcerative colitis	1.05e-05	0.00168	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—TNF—ulcerative colitis	1.04e-05	0.00167	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—ulcerative colitis	9.88e-06	0.00158	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—TNF—ulcerative colitis	9.88e-06	0.00158	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—CHP1—ulcerative colitis	9.63e-06	0.00154	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—SEL1L—ulcerative colitis	9.14e-06	0.00146	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	9.03e-06	0.00145	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—TGFB1—ulcerative colitis	8.8e-06	0.00141	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—IL6—ulcerative colitis	8.39e-06	0.00134	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—DLD—ulcerative colitis	8.31e-06	0.00133	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—TNF—ulcerative colitis	8.22e-06	0.00132	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—LTF—ulcerative colitis	8.19e-06	0.00131	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—TP53—ulcerative colitis	7.25e-06	0.00116	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	7.19e-06	0.00115	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CHP1—ulcerative colitis	7e-06	0.00112	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	6.79e-06	0.00109	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—IL6—ulcerative colitis	6.63e-06	0.00106	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	6.55e-06	0.00105	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CHP1—ulcerative colitis	6.38e-06	0.00102	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PTGS1—ulcerative colitis	6.21e-06	0.000995	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	6.11e-06	0.000979	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—DLD—ulcerative colitis	6.04e-06	0.000968	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	5.99e-06	0.00096	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	5.98e-06	0.000958	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—SLC11A1—ulcerative colitis	5.84e-06	0.000936	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—CALM3—ulcerative colitis	5.59e-06	0.000896	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	5.59e-06	0.000896	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	5.54e-06	0.000888	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—DLD—ulcerative colitis	5.51e-06	0.000882	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CHP1—ulcerative colitis	5.45e-06	0.000874	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	5.34e-06	0.000857	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—MAML2—ulcerative colitis	5.25e-06	0.000841	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	5.11e-06	0.000819	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	4.98e-06	0.000798	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	4.93e-06	0.00079	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—DLD—ulcerative colitis	4.7e-06	0.000754	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—CALM3—ulcerative colitis	4.56e-06	0.000731	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	4.4e-06	0.000705	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	4.36e-06	0.000698	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—ABCB1—ulcerative colitis	4.35e-06	0.000697	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CALM3—ulcerative colitis	4.32e-06	0.000693	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—ADCY5—ulcerative colitis	4.06e-06	0.00065	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PTGS1—ulcerative colitis	4.02e-06	0.000644	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	3.95e-06	0.000634	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—CALM3—ulcerative colitis	3.62e-06	0.00058	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—ABCB1—ulcerative colitis	3.55e-06	0.000568	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—ADCY5—ulcerative colitis	3.31e-06	0.00053	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	3.19e-06	0.000512	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—ADCY5—ulcerative colitis	3.13e-06	0.000502	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PPARG—ulcerative colitis	3.03e-06	0.000485	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PTGS1—ulcerative colitis	2.92e-06	0.000468	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	2.91e-06	0.000467	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	2.87e-06	0.00046	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—ABCB1—ulcerative colitis	2.81e-06	0.000451	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—ALB—ulcerative colitis	2.72e-06	0.000436	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PTGS1—ulcerative colitis	2.66e-06	0.000427	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CALM3—ulcerative colitis	2.63e-06	0.000421	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—ADCY5—ulcerative colitis	2.63e-06	0.000421	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	2.62e-06	0.00042	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	2.51e-06	0.000403	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	2.49e-06	0.000399	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PPARG—ulcerative colitis	2.47e-06	0.000395	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CALM3—ulcerative colitis	2.4e-06	0.000384	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PTGS2—ulcerative colitis	2.38e-06	0.000381	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	2.29e-06	0.000367	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PTGS1—ulcerative colitis	2.27e-06	0.000365	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	2.24e-06	0.000359	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—ALB—ulcerative colitis	2.22e-06	0.000355	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CALM3—ulcerative colitis	2.05e-06	0.000328	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—ABCB1—ulcerative colitis	2.04e-06	0.000328	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PPARG—ulcerative colitis	1.96e-06	0.000314	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.96e-06	0.000314	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—JAK2—ulcerative colitis	1.95e-06	0.000313	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PTGS2—ulcerative colitis	1.94e-06	0.000311	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—ADCY5—ulcerative colitis	1.91e-06	0.000306	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—ABCB1—ulcerative colitis	1.86e-06	0.000299	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CD4—ulcerative colitis	1.85e-06	0.000297	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—ALB—ulcerative colitis	1.76e-06	0.000282	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—ADCY5—ulcerative colitis	1.74e-06	0.000279	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—ABCB1—ulcerative colitis	1.59e-06	0.000255	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—ADCY5—ulcerative colitis	1.49e-06	0.000238	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—STAT3—ulcerative colitis	1.43e-06	0.00023	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PPARG—ulcerative colitis	1.42e-06	0.000228	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—TGFB1—ulcerative colitis	1.33e-06	0.000213	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PPARG—ulcerative colitis	1.3e-06	0.000208	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—ALB—ulcerative colitis	1.28e-06	0.000205	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—ALB—ulcerative colitis	1.17e-06	0.000187	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PTGS2—ulcerative colitis	1.12e-06	0.000179	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PPARG—ulcerative colitis	1.11e-06	0.000178	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PTGS2—ulcerative colitis	1.02e-06	0.000163	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—IL6—ulcerative colitis	1e-06	0.000161	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—ALB—ulcerative colitis	9.96e-07	0.00016	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PTGS2—ulcerative colitis	8.72e-07	0.00014	CbGpPWpGaD
